TIMOTHY C WENTWORTH

CIK 1252016 · Chief Executive Officer · last filed 2026-07-02

TIMOTHY C WENTWORTH is a Chief Executive Officer who has filed 77 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for DGX, was dated Jul 2, 2026. Across all open-market trades the lifetime net is −$45.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $17.5M across reported positions. 5 SEC filings were submitted jointly with QUEST DIAGNOSTICS INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$17.52M

Companies

5

Total Filings

77

Lifetime Open-Market Net

-$45.53M

Filer Profile

Reported Address
C/O WALGREENS BOOTS ALLIANCE, INC.
108 WILMOT ROAD
DEERFIELD, IL 60015
Related Filers
QUEST DIAGNOSTICS INC — 5 joint filings, latest 2026-07-02
Walgreens Boots Alliance, Inc. — 5 joint filings, latest 2025-08-28
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DGX Director 1,358 $235.02 $319.2K $0 4 2026-07-02
Walgreens Boots Alliance, Inc. (WBA) Delisted Chief Executive Officer 0 $11.98 $0 $242.2K 4 2025-08-28
CI CEO Evernorth 61,267 $280.76 $17.20M -$27.14M 20 2021-05-13
Express Scripts Holding Co. (ESRX) Delisted President & CEO 0 $489.0K 21 2018-12-21
MEDCO HEALTH SOLUTIONS INC (MHS) Delisted Group Pres, Employer Accounts 0 -$19.12M 28 2012-04-03

Recent Filings

77 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-02 DGX Grant (A) $0 EDGAR
2026-05-21 DGX Grant (A) +1,142 $0 EDGAR
2026-04-02 DGX Grant (A) $0 EDGAR
2026-03-11 DGX Grant (A) +215 $0 EDGAR
2025-08-28 Walgreens Boots Alliance, Inc. (WBA) Delisted Disp (D) −1,332,014 $0 EDGAR
2024-11-05 Walgreens Boots Alliance, Inc. (WBA) Delisted Mixed +683,890 -$739.2K EDGAR
2024-01-08 Walgreens Boots Alliance, Inc. (WBA) Delisted Buy (P) +10,000 $242.2K EDGAR
2023-11-03 Walgreens Boots Alliance, Inc. (WBA) Delisted Grant (A) +562,324 $0 EDGAR
2021-05-13 CI Gift (G) −11,150 $0 EDGAR
2021-04-19 CI Mixed +6,087 -$1.59M EDGAR
Showing 110 of 77
Page 1 of 8
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.